4-Iodobenzylamine, 97%
4-Iodobenzylamine, 97%
4-Iodobenzylamine, 97%
Thermo Scientific Chemicals

4-Iodobenzylamine, 97%

CAS: 39959-59-6 | C7H8IN | 233.052 g/mol
製品番号(カタログ番号) L17450.03
または、製品番号L17450-03
価格(JPY)
-
数量:
1 g
一括またはカスタム形式をリクエストする
化学物質識別子
CAS39959-59-6
IUPAC Name1-(4-iodophenyl)methanamine
Molecular FormulaC7H8IN
InChI KeyKCGZGJOBKAXVSU-UHFFFAOYSA-N
SMILESNCC1=CC=C(I)C=C1
さらに表示
Appearance (Color)White to cream to pale brown
FormCrystals or powder or crystalline powder or lumps or fused solid
Assay (Non-aqueous acid-base Titration)≥96.0 to ≤104.0%
Assay (GC)≥96.0%
Melting Point (clear melt)41.0-51.0?C
4-Iodobenzylamine is used to prepare 2-bromo-N-(4-iodo-benzyl)-acetamide in the presence of bromoacetyl bromide.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
4-Iodobenzylamine is used to prepare 2-bromo-N-(4-iodo-benzyl)-acetamide in the presence of bromoacetyl bromide.

Solubility
Slightly soluble in water.

Notes
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. It is sensitive to air and light. Incompatible with oxidizing agents.
RUO – Research Use Only

General References:

  1. Louise Stevenson.; Adriana A.S. Tavares.; Aurélie Brunet.; Fiona I. McGonagle.; Deborah Dewar.; Sally L. Pimlott.; Andrew Sutherland. New iodinated quinoline-2-carboxamides for SPECT imaging of the translocator protein. Bioorganic & Medicinal Chemistry Letters. 2010, 20 (3), 954-957.
  2. R. N. Garman.; M. J. Hickey.; L. P. Kingston.; B. McAuley.; J. R. Jones.; W. J. S. Lockley.; A. N. Mather.; D. J. Wilkinson. Labelling of anilines, benzylamines and some N-heterocyclics using cycloocta-1,5-dienyliridium(I)-1,1,1,5,5,5-hexafluoro-pentan-2,4-dionate and isotopic hydrogen gas in DMF or DMA. Journal of Labelled Compounds and Radiopharmaceuticals. 2005, 48 (1), 75-84.